Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cadence Design Systems Inc (CDNS) vs Revvity Inc (RVTY) Price & Performance

Cadence Design Systems IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Cadence Design Systems Inc vs Revvity Inc — how do they compare? Cadence Design Systems Inc trades at $325.54 (market cap $90.20B), while Revvity Inc trades at $116.5 (market cap $12.91B). The key difference: Cadence Design Systems Inc is far larger — about 7× Revvity Inc's market cap, and Revvity Inc pays a 0.24% dividend while Cadence Design Systems Inc pays none. Which is the better fit depends on your goals.

CDNSRVTY
Market Cap
$90.20B$12.91B
Sector
TechnologyTechnology
52-Week High
$416.39$117.75
52-Week Low
$265.66$82.26
Enterprise Value
$91.41B$15.23B
Dividend Yield
0.24%

Returns comparison

Trailing returns across standard periods

About Cadence Design Systems Inc

Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.

Read more on CDNS

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY